Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced the appointment of David Kenigsberg, M.D. as Chief...
Pulse Biosciences, Inc, a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced that it has received the Breakthrough Device Designation...
